Composition
- Active ingredients
- BACITRACIN ZINC 400 UNITS/GM; HYDROCORTISONE 1%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM; POLYMYXIN B SULFATE 5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BACITRACIN ZINC 400 UNITS/GM; HYDROCORTISONE 1%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM; POLYMYXIN B SULFATE 10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · OintmentNDA050416-002 · Discontinued
- BACITRACIN ZINC 400 UNITS/GM; HYDROCORTISONE 1%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM; POLYMYXIN B SULFATE 5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · OintmentThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050168.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cortisporin
- Active substance
- bacitracin zinc
- Route
- Topical
- Dosage form
- Ointment
- Applicant
- Monarch Pharms
- Status
- Discontinued
- FDA approval
- 26 Mar 1957
- Application
- NDA050168-002